| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Analysing materials | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides | |
| #5 | Sugars | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hamilton Douglas A | 6 |
| #2 | Blois Anna L | 6 |
| #3 | Buck Elizabeth A | 5 |
| #4 | O'Connor Matthew | 5 |
| #5 | Glinskii Guennadi V | 3 |
| Publication | Filing date | Title |
|---|---|---|
| KR20190064562A | Methods and compositions for chemotherapeutic therapy targeting MENA protein isoform kinase | |
| WO2016191471A1 | Method of use for inhibitors of epidermal growth factor receptor variants ii, iii and vi | |
| US2018271853A1 | Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variant III | |
| WO2016112302A1 | Method of predicting sensitivity of tumor cell growth to combination therapy of fgfr inhibitor | |
| AU2827595A | Synthetic glycoamines that promote or inhibit cell adhesion |